Hold Ipca Laboratories; target of Rs 262: PINC Research – MoneyControl.com

The company’s key therapeutic segments namely Anti-malaria, Anti-infective and CNS have witnessed de-growth in the last few months. As a result, we now estimate Ipca’s highmargin domestic formulation business to grow below industry average …